Invus Public Equities, L.P.

Insider Reports History

Identity
Location
New York, NY
SEC record
Reporting signature
Invus Public Equities, L.P., By: Invus Public Equities Advisors, LLC, its General Partner, By: /s/ Raymond Debbane, President
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Invus Public Equities, L.P.:

Form 4 holding 10%+ Owner

Scholar Rock Holding Corp

Security class
Common Stock
Shares / value
9,250,005
Estimated value
$385,262,708
Report date
10 Dec 2024
Price
$41.65
Ownership
Direct
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,273,530
Estimated value
$18,188,240
Report date
03 Aug 2021
Price
$8.00
Ownership
Direct
Form 4 holding 10%+ Owner

GLYCOMIMETICS INC

Security class
Common Stock
Shares / value
6,317,565
Estimated value
$1,211,077
Report date
08 Aug 2024
Price
$0.1917
Ownership
Direct
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Series C Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Invus Public Equities, L.P.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .